IndustryPayments
Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

MEGAN BERGERON

Allopathic & Osteopathic Physicians Psychiatry & Neurology Psychiatry

NPI
1649850124
CMS profile
8873914
Location
HOUMA, LA

General Payments · PY2021–2024

$2,777.95

  • Reported across 125 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$1,311.61

56 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

Related groups: Psychiatry LA All categories

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $1,311.61 56

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
ABBVIE INC. $368.17 16
Alkermes, Inc. $260.45 14
Neurocrine BioSciences, Inc. $171.89 7
Axsome Therapeutics, Inc. $167.82 8
ITI, Inc. $94.29 1
Vanda Pharmaceuticals Inc. $85.36 1
Teva Pharmaceuticals USA, Inc. $38.97 2
Supernus Pharmaceuticals, Inc. $35.35 2
Merck Sharp & Dohme Corporation $32.39 2
Takeda Pharmaceuticals U.S.A., Inc. $22.72 1
Exact Sciences Corporation $20.06 1
Corium, Inc. $14.14 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2021 $654.79 30
PY2022 $292.57 15
PY2023 $518.98 24
PY2024 $1,311.61 56

Payment records · PY2024 (56)

Sorted by paying entity, then date · as published by CMS

Program year 2024 202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $22.74 01/04/2024 Food and Beverage Undisputed 01/23/2026 1103311942 CMS
ABBVIE INC. $31.58 01/09/2024 Food and Beverage Undisputed 01/23/2026 1103311944 CMS
ABBVIE INC. $29.59 03/21/2024 Food and Beverage Undisputed 01/23/2026 1103311946 CMS
ABBVIE INC. $2.93 03/28/2024 Food and Beverage Undisputed 01/23/2026 1103311948 CMS
ABBVIE INC. $33.06 04/03/2024 Food and Beverage Undisputed 01/23/2026 1103311950 CMS
ABBVIE INC. $23.33 04/24/2024 Food and Beverage Undisputed 01/23/2026 1103311952 CMS
ABBVIE INC. $27.66 05/09/2024 Food and Beverage Undisputed 01/23/2026 1103311954 CMS
ABBVIE INC. $31.03 05/13/2024 Food and Beverage Undisputed 01/23/2026 1103311956 CMS
ABBVIE INC. $24.09 05/13/2024 Food and Beverage Undisputed 01/23/2026 1103311958 CMS
ABBVIE INC. $25.66 06/06/2024 Food and Beverage Undisputed 01/23/2026 1103311960 CMS
ABBVIE INC. $22.24 07/02/2024 Food and Beverage Undisputed 01/23/2026 1103311962 CMS
ABBVIE INC. $21.46 07/15/2024 Food and Beverage Undisputed 01/23/2026 1103311964 CMS
ABBVIE INC. $24.41 08/06/2024 Food and Beverage Undisputed 01/23/2026 1103311966 CMS
ABBVIE INC. $18.30 10/08/2024 Food and Beverage Undisputed 01/23/2026 1103311968 CMS
ABBVIE INC. $6.16 10/23/2024 Food and Beverage Undisputed 01/23/2026 1103311970 CMS
ABBVIE INC. $23.93 11/12/2024 Food and Beverage Undisputed 01/23/2026 1103311972 CMS
Alkermes, Inc. $14.36 02/29/2024 Food and Beverage Undisputed 01/23/2026 1120466389 CMS
Alkermes, Inc. $0.76 04/23/2024 Food and Beverage Undisputed 01/23/2026 1120466391 CMS
Alkermes, Inc. $15.18 04/23/2024 Food and Beverage Undisputed 01/23/2026 1120466393 CMS
Alkermes, Inc. $1.85 04/29/2024 Food and Beverage Undisputed 01/23/2026 1120466395 CMS
Alkermes, Inc. $13.51 04/30/2024 Food and Beverage Undisputed 01/23/2026 1120466397 CMS
Alkermes, Inc. $11.86 08/29/2024 Food and Beverage Undisputed 01/23/2026 1120466399 CMS
Alkermes, Inc. $12.90 09/17/2024 Food and Beverage Undisputed 01/23/2026 1120466401 CMS
Alkermes, Inc. $12.77 10/03/2024 Food and Beverage Undisputed 01/23/2026 1120466403 CMS
Alkermes, Inc. $91.25 10/03/2024 Food and Beverage Undisputed 01/23/2026 1120466405 CMS
Alkermes, Inc. $0.76 10/10/2024 Food and Beverage Undisputed 01/23/2026 1120466407 CMS
Alkermes, Inc. $14.15 10/10/2024 Food and Beverage Undisputed 01/23/2026 1120466409 CMS
Alkermes, Inc. $12.99 11/01/2024 Food and Beverage Undisputed 01/23/2026 1120466411 CMS
Alkermes, Inc. $34.29 11/13/2024 Food and Beverage Undisputed 01/23/2026 1120466413 CMS
Alkermes, Inc. $23.82 12/06/2024 Food and Beverage Undisputed 01/23/2026 1120466415 CMS
Axsome Therapeutics, Inc. $17.77 05/31/2024 Food and Beverage Undisputed 01/23/2026 1148391702 CMS
Axsome Therapeutics, Inc. $12.87 08/08/2024 Food and Beverage Undisputed 01/23/2026 1148391704 CMS
Axsome Therapeutics, Inc. $16.82 08/27/2024 Food and Beverage Undisputed 01/23/2026 1148391712 CMS
Axsome Therapeutics, Inc. $90.96 08/28/2024 Food and Beverage Undisputed 01/23/2026 1148391706 CMS
Axsome Therapeutics, Inc. $14.97 10/15/2024 Food and Beverage Undisputed 01/23/2026 1148391708 CMS
Axsome Therapeutics, Inc. $0.82 10/15/2024 Food and Beverage Undisputed 01/23/2026 1148391710 CMS
Axsome Therapeutics, Inc. $13.19 11/07/2024 Food and Beverage Undisputed 01/23/2026 1148391714 CMS
Axsome Therapeutics, Inc. $0.42 11/07/2024 Food and Beverage Undisputed 01/23/2026 1148391716 CMS
Corium, LLC $14.14 09/05/2024 Food and Beverage Undisputed 01/23/2026 1100162559 CMS
Exact Sciences Corporation $20.06 10/17/2024 Food and Beverage Undisputed 01/23/2026 1128385344 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $94.29 01/31/2024 Food and Beverage Undisputed 01/23/2026 1143374899 CMS
Merck Sharp & Dohme LLC $16.38 10/24/2024 Food and Beverage Undisputed 01/23/2026 1141803293 CMS
Merck Sharp & Dohme LLC $16.01 11/22/2024 Food and Beverage Undisputed 01/23/2026 1141803291 CMS
Neurocrine Biosciences, Inc. $0.71 01/15/2024 Food and Beverage Undisputed 01/23/2026 1151029140 CMS
Neurocrine Biosciences, Inc. $31.12 01/18/2024 Food and Beverage Undisputed 01/23/2026 1150937374 CMS
Neurocrine Biosciences, Inc. $34.23 03/28/2024 Food and Beverage Undisputed 01/23/2026 1150932922 CMS
Neurocrine Biosciences, Inc. $23.39 08/27/2024 Food and Beverage Undisputed 01/23/2026 1150962156 CMS
Neurocrine Biosciences, Inc. $35.61 10/01/2024 Food and Beverage Undisputed 01/23/2026 1150931589 CMS
Neurocrine Biosciences, Inc. $21.67 10/29/2024 Food and Beverage Undisputed 01/23/2026 1150971475 CMS
Neurocrine Biosciences, Inc. $25.16 11/25/2024 Food and Beverage Undisputed 01/23/2026 1150954479 CMS
Supernus Pharmaceuticals, Inc. $15.24 04/08/2024 Food and Beverage Undisputed 01/23/2026 1147876817 CMS
Supernus Pharmaceuticals, Inc. $20.11 07/18/2024 Food and Beverage Undisputed 01/23/2026 1147876815 CMS
Takeda Pharmaceuticals U.S.A., Inc. $22.72 05/21/2024 Food and Beverage Undisputed 01/23/2026 1137713345 CMS
Teva Pharmaceuticals USA, Inc. $19.69 02/19/2024 Food and Beverage Undisputed 01/23/2026 1151576653 CMS
Teva Pharmaceuticals USA, Inc. $19.28 06/13/2024 Food and Beverage Undisputed 01/23/2026 1151576675 CMS
Vanda Pharmaceuticals Inc. $85.36 06/26/2024 Food and Beverage Undisputed 01/23/2026 1133931414 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.